Out of 30 cross‑vertical startups, Amarastesia’s CerAMvix was awarded InnovX’s top innovation prize by a panel of investors, mentors,...

The USPTO’s Notice of Allowance confirms there was no prior art to challenge any of our 24 claims — a rare validation that highlights...

Amarastesia celebrates another milestone with a written notification from the EPO on the patentability of cerA&Mvix. While filing a...